Cytomos Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 31

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $7.79M

  • Investors
  • 5

Cytomos General Information

Description

Developer of a dielectric spectroscopy technology designed to assist with label-free cell analysis for biomedical research. The company's patented cell analysis technology ensures that every cell is analyzed providing granular information on individual cells and the whole sample population, facilitates automated and quantitative sample assessment, phenotypic drug discovery, and stem cell therapy, enabling medical researchers to find functional endpoints that generate content fingerprints to prepare the right dose thereby making cell-based diagnostics efficient.

Contact Information

Website
www.cytomos.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1st Floor, Charles Darwin House
  • Milton Bridge, The Edinburgh Technopole
  • Edinburgh EH26 0PY
  • Scotland, United Kingdom
+44 0131
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Laboratory Services (Healthcare)
Vertical(s)
Life Sciences
Corporate Office
  • 1st Floor, Charles Darwin House
  • Milton Bridge, The Edinburgh Technopole
  • Edinburgh EH26 0PY
  • Scotland, United Kingdom
+44 0131

Cytomos Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cytomos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 29-Oct-2024 $7.79M Completed Generating Revenue
7. Grant 01-Dec-2022 Completed Generating Revenue
6. Seed Round 28-Jun-2022 Completed Generating Revenue
5. Seed Round 24-May-2021 Completed Startup
4. Seed Round 26-Jun-2020 Completed Startup
3. Seed Round 23-Apr-2018 Completed Startup
2. Seed Round 01-Mar-2016 $768K $925K Completed Startup
1. Seed Round 15-Dec-2014 $157K $157K Completed Startup
To view Cytomos’s complete valuation and funding history, request access »

Cytomos Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary 35,295 $0.000013 $8.91 $8.91 1x $8.91 2.39%
Ordinary 126,050 $0.000013 $6.63 $6.63 1x $6.63 8.55%
To view Cytomos’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Cytomos Patents

  • 19

    Total Documents Applications and Grants

  • Total Patents Families

  • 6

    Granted

  • 10

    Pending

  • Expiring in next 12 mo

Cytomos Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202414700-D0 Cell analysis Pending 07-Oct-2024
GB-202413794-D0 Cell analysis Pending 19-Sep-2024
GB-202318310-D0 Cell selection Pending 30-Nov-2023
GB-202411710-D0 Cell selection Inactive 30-Nov-2023
GB-2636141-A Cell selection Pending 30-Nov-2023 G01N15/1023
To view Cytomos’s complete patent history, request access »

Cytomos Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cytomos Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
British Business Bank Lender/Debt Provider Minority
Innovate UK Government
Old College Capital Corporate Venture Capital Minority
Scottish Enterprise Government Minority
Archangel Investors Angel Group Minority
To view Cytomos’s complete investors history, request access »

Ready to get started?

Request a free trial

Cytomos FAQs

  • When was Cytomos founded?

    Cytomos was founded in 2011.

  • Where is Cytomos headquartered?

    Cytomos is headquartered in Edinburgh, United Kingdom.

  • What is the size of Cytomos?

    Cytomos has 31 total employees.

  • What industry is Cytomos in?

    Cytomos’s primary industry is Biotechnology.

  • Is Cytomos a private or public company?

    Cytomos is a Private company.

  • What is the current valuation of Cytomos?

    The current valuation of Cytomos is .

  • What is Cytomos’s current revenue?

    The current revenue for Cytomos is .

  • How much funding has Cytomos raised over time?

    Cytomos has raised $15.4M.

  • Who are Cytomos’s investors?

    British Business Bank, Innovate UK, Old College Capital, Scottish Enterprise, and Archangel Investors have invested in Cytomos.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »